ArticleCancer cell international2023

HER3 functions as an effective therapeutic target in triple negative breast cancer to potentiate the antitumor activity of gefitinib and paclitaxel.

Hui Lyu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.